NMR with Combined Antiangiogenic and Radiation Therapies - Breast Cancer
Abstract
New therapies that target tumor vasculature are receiving intense attention because they exhibit their effect preferentially on tumor vasculature compared with that of normal tissue. New therapies are combined with conventional treatment; radiation therapy is a standard therapy for breast cancer. There are reasons to believe timing of drug and radiation would be important. The proposal is designed to investigate the effect of sequence and timing on tumor response following the combined adminiistration of drug and radiation. Furthermore, non-invasive tools for measuring blood flow and oxygen are used which have a potential direct clinical utility.
Document Details
- Document Type
- Technical Report
- Publication Date
- May 01, 2002
- Accession Number
- ADA413368
Entities
People
- Stephen L. Brown
Organizations
- Henry Ford Health